Zidovudine 300mg, Lamivudine 150mg, Nevirapine Tablets IP
Zidovudine (300mg) + Lamivudine (150mg)
Zidovudine (300mg) + Lamivudine (150mg) is an antiretroviral combination therapy to treat HIV virus. The recommended tablet dose of the tablet depends upon the age of the patient and recommended by your doctor.
It is white to off-white tablet, capsule shaped, biconvex tablet debossed with ‘M’ on left of the score line and ‘103’ on the right side of the tablet and it can be divided into equal doses.
Zidovudine: It is a yellowish powder and nucleoside analog reverse transcriptase inhibitor (NRTI) and inhibits the enzyme reverse transcriptase. HIV uses this enzyme to make DNA and increase the inspection.
Zidovudine decreases the replication of the virus.
Lamivudine: It is a synthetic nucleoside and a (-) enantiomer of a dideoxy analog of cytidine. It is white to off- white crystalline solid and it is phosphorylated intracellularly to its active 5-triphosphate metabolite. It blocks the reverse transcriptase that HIV needs to make DNA and decreases the replication of the virus.
It is used for the treatment HIV infections in both adults and children depending upon their age. It prevents the HIV infections multiplying in the body.
The medicine controls the HIV infections in the blood and reduces the risk of AIDS in the body.
It acts as an immunity booster and reduces the production of new viruses or infections in the body.
The combination has the inhibitors which blocks the viral enzymes and decreases the effects of virus on the body and avoids complications of HIV.
Monitor your liver, heart, and kidneys health regularly while taking this medicine.
Talk to your doctor about all the side effects, risks, and contradictions to avoid serious reactions of the medicine and worsening of the health.
Do not skip or discontinue the medicine unless your doctor suggests or it may affect the treatment and increase the effects of virus on the body.